Feedback / Questions
DM919 - D2M biotherap
https://www.prnewswire.com/news-releases/d2m-biotherapeutics-announces-first-patient-dosed-in-a-phase-1-study-evaluating-302120400.html
Apr 18, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next